{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:58:48Z","timestamp":1740124728643,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1038\/s41393-022-00755-4","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T14:02:33Z","timestamp":1643464953000},"page":"687-693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preventive treatment with alendronate of loss of bone mineral density in acute traumatic spinal cord injury. Randomized controlled clinical trial"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3823-4649","authenticated-orcid":false,"given":"Mar\u00eda Teresa","family":"Fern\u00e1ndez Dorado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Sagrario","family":"D\u00edaz Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Garc\u00eda Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Cuena Boy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Blanco Samper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Mart\u00ednez Dhier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Labarta Bertol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"755_CR1","first-page":"674","volume":"33","author":"E Wilmet","year":"1995","unstructured":"Wilmet E, Ismail AA, Heilporn A, Welraeds D, Bergmann P. Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section. Paraplegia. 1995;33:674\u20137.","journal-title":"Paraplegia."},{"key":"755_CR2","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.metabol.2011.04.005","volume":"60","author":"L Ma\u00efmoun","year":"2011","unstructured":"Ma\u00efmoun L, Fattal C, Sultan C. Bone remodeling and calcium homeostasis in patients with spinal cord injury: A review. Metabolism. 2011;60:1655\u201363.","journal-title":"Metabolism."},{"key":"755_CR3","first-page":"415","volume":"83","author":"D Roberts","year":"1998","unstructured":"Roberts D, Lee W, Cuneo RC, Wittman J, Ward G, Flatman R, et al. Longitudinal study of bone turnover after acute spinal cord injury. J Clin Endocrinol Metab. 1998;83:415\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"755_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00198-003-1529-6","volume":"15","author":"Y Zehnder","year":"2004","unstructured":"Zehnder Y, L\u00fcthi M, Michel D, Knecht H, Perrelet R, Neto I, et al. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: A cross-sectional observational study in 100 paraplegic men. Osteoporos Int. 2004;15:180\u20139.","journal-title":"Osteoporos Int"},{"key":"755_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.rehab.2010.10.001","volume":"53","author":"C Charmetant","year":"2010","unstructured":"Charmetant C, Phaner V, Condemine A, Calmels P. Diagnosis and treatment of osteoporosis in spinal cord injury patients: A literature review [published correction appears in Ann Phys Rehabil Med. 2011 Jun;54(4):271]. Ann Phys Rehabil Med. 2010;53:655\u201368.","journal-title":"Ann Phys Rehabil Med."},{"key":"755_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/sj.sc.3101139","volume":"39","author":"MG Lazo","year":"2001","unstructured":"Lazo MG, Shirazi P, Sam M, Giobbie-Hurder A, Blacconiere MJ, Muppidi M. Osteoporosis and risk of fracture in men with spinal cord injury. Spinal Cord. 2001;39:208\u201314.","journal-title":"Spinal Cord"},{"key":"755_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.bone.2004.01.001","volume":"34","author":"P Eser","year":"2004","unstructured":"Eser P, Frotzler A, Zehnder Y, Wick L, Knecht H, Denoth J, et al. Relationship between the duration of paralysis and bone structure: A pQCT study of spinal cord injured individuals. Bone. 2004;34:869\u201380.","journal-title":"Bone."},{"key":"755_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jbmr.5650100116","volume":"10","author":"D Chappard","year":"1995","unstructured":"Chappard D, Minaire P, Privat C, Berard E, Mendoza-Sarmiento J, Tournebise H, et al. Effects of tiludronate on bone loss in paraplegic patients. J Bone Min Res. 1995;10:112\u20138.","journal-title":"J Bone Min Res"},{"key":"755_CR9","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1210\/jc.2006-2013","volume":"92","author":"NL Gilchrist","year":"2007","unstructured":"Gilchrist NL, Frampton CM, Acland RH, Nicholls MG, March RL, Maguire P, et al. Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2007;92:1385\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"755_CR10","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1172\/JCI110331","volume":"68","author":"P Minaire","year":"1981","unstructured":"Minaire P, Berard E, Meunier PJ, Edouard C, Goedert G, Pilonchery G. Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients. J Clin Invest. 1981;68:1086\u201392.","journal-title":"J Clin Invest"},{"key":"755_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0003-9993(97)90032-0","volume":"78","author":"EG Pearson","year":"1997","unstructured":"Pearson EG, Nance PW, Leslie WD, Ludwig S. Cyclical etidronate: Its effect on bone density in patients with acute spinal cord injury. Arch Phys Med Rehabil. 1997;78:269\u201372.","journal-title":"Arch Phys Med Rehabil"},{"key":"755_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00223-007-9012-6","volume":"80","author":"J Shapiro","year":"2007","unstructured":"Shapiro J, Smith B, Beck T, Ballard P, Dapthary M, BrintzenhofeSzoc K, et al. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury. Calcif Tissue Int. 2007;80:316\u201322.","journal-title":"Calcif Tissue Int"},{"key":"755_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1682\/JRRD.2004.05.0062","volume":"42","author":"WA Bauman","year":"2005","unstructured":"Bauman WA, Wecht JM, Kirshblum S, Spungen AM, Morrison N, Cirnigliaro C, et al. Effect of pamidronate administration on bone in patients with acute spinal cord injury. J Rehabil Res Dev. 2005;42:305\u201313.","journal-title":"J Rehabil Res Dev"},{"key":"755_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-010-1221-6","volume":"22","author":"JS Bubbear","year":"2011","unstructured":"Bubbear JS, Gall A, Middleton FR, Ferguson-Pell M, Swaminathan R, Keen RW. Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury. Osteoporos Int. 2011;22:271\u20139.","journal-title":"Osteoporos Int"},{"key":"755_CR15","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1359\/JBMR.040512","volume":"19","author":"DC Bauer","year":"2004","unstructured":"Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: The fracture intervention trial. J Bone Min Res. 2004;19:1250\u20138.","journal-title":"J Bone Min Res"},{"key":"755_CR16","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/clinchem\/44.11.2290","volume":"44","author":"S Christgau","year":"1998","unstructured":"Christgau S, Rosenquist C, Alexandersen P, Bjarnason NH, Ravn P, Fledelius C, et al. Clinical evaluation of the serum cross laps one step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clin Chem. 1998;44:2290\u2013300.","journal-title":"Clin Chem"},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/PL00005830","volume":"66","author":"HN Rosen","year":"2000","unstructured":"Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, et al. Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int. 2000;66:100\u20133.","journal-title":"Calcif Tissue Int"},{"key":"755_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/10790268.2010.11689698","volume":"33","author":"W Bauman","year":"2010","unstructured":"Bauman W, Kirshblum S, Cirnigliaro C, Forrest G, Spungen A. Underestimation of bone loss of the spine with posterior-anterior dual-energy X-ray absorptiometry in patients with spinal cord injury. J Spinal Cord Med. 2010;33:214\u201320.","journal-title":"J Spinal Cord Med"},{"key":"755_CR19","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/s00586-017-5114-7","volume":"27","author":"S Soleyman-Jahi","year":"2018","unstructured":"Soleyman-Jahi S, Yousefian A, Maheronnaghsh R, Shokraneh F, Zadegan SA, Soltani A, et al. Evidence-based prevention and treatment of osteoporosis after spinal cord injury: A systematic review. Eur Spine J. 2018;27:1798\u2013814.","journal-title":"Eur Spine J"},{"key":"755_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pmrj.2014.08.948","volume":"7","author":"WA Bauman","year":"2015","unstructured":"Bauman WA, Cardozo CP. Osteoporosis in individuals with spinal cord injury. PM R 2015;7:188\u2013201.","journal-title":"PM R"},{"key":"755_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00198-016-3798-x","volume":"28","author":"CM Cirnigliaro","year":"2017","unstructured":"Cirnigliaro CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, Forrest GF, Bauman WA. Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options. Osteoporos Int. 2017;28:747\u201365.","journal-title":"Osteoporos Int"},{"key":"755_CR22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.pmrj.2016.01.012","volume":"8","author":"TJ Schnitzer","year":"2016","unstructured":"Schnitzer TJ, Kim K, Marks J, Yeasted R, Simonian N, Chen D. Zoledronic acid treatment after acute spinal cord injury: Results of a randomized, placebo-controlled pilot Trial PM R. 2016;8:833\u201343.","journal-title":"PM R"},{"key":"755_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00774-014-0602-x","volume":"33","author":"WA Bauman","year":"2015","unstructured":"Bauman WA, Cirnigliaro CM, La Fountaine MF, Martinez L, Kirshblum SC, Spungen AM. Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: An observational cohort study. J Bone Miner Metab. 2015;33:410\u201321.","journal-title":"J Bone Miner Metab"},{"key":"755_CR24","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41393-018-0195-7","volume":"56","author":"S Goenka","year":"2018","unstructured":"Goenka S, Sethi S, Pandey N, Joshi M, Jindal R. Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial. Spinal Cord. 2018;56:1207\u201311.","journal-title":"Spinal Cord"},{"key":"755_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41393-020-0431-9","volume":"58","author":"CV Oleson","year":"2020","unstructured":"Oleson CV, Marino RJ, Formal CS, Modlesky CM, Leiby BE. The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study. Spinal Cord. 2020;58:921\u20139.","journal-title":"Spinal Cord"},{"key":"755_CR26","doi-asserted-by":"publisher","unstructured":"Cirnigliaro CM, La Fountaine MF, Parrott JS, Kirshblum SC, McKenna C, Sauer SJ, et al. Administration of denosumab preserves bone mineral density at the knee in persons with subacute spinal cord injury: findings from a randomized clinical trial. JBMR Plus (WOA), 2020; https:\/\/doi.org\/10.1002\/jbm4.10375","DOI":"10.1002\/jbm4.10375"},{"key":"755_CR27","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1007\/s00198-017-4090-4","volume":"28","author":"L Gifre","year":"2017","unstructured":"Gifre L, Ruiz-Gasp\u00e0 S, Carrasco JL, Portell E, Vidal J, Muxi A, et al. Effect of recent spinal cord injury on the OPG\/RANKL system and its relationship with bone loss and the response to denosumab therapy. Osteoporos Int. 2017;28:2707\u201315.","journal-title":"Osteoporos Int"},{"key":"755_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00198-015-3333-5","volume":"27","author":"L Gifre","year":"2016","unstructured":"Gifre L, Vidal J, Carrasco JL, Muxi A, Portell E, Monegal A, et al. Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury. Osteoporos Int. 2016;27:405\u201310.","journal-title":"Osteoporos Int"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41393-022-00755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-022-00755-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-022-00755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T14:04:34Z","timestamp":1661177074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-022-00755-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1038\/s41393-022-00755-4","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"type":"print","value":"1362-4393"},{"type":"electronic","value":"1476-5624"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"29 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The trial was approved by the Ethics Committee of Clinical Research of the Health Area of Toledo and the Clinical Research Committee of the National Hospital for Paraplegics (Hospital Nacional de Parapl\u00e9jicos\u2014HNP) of Toledo (Spain).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}